NCT03570528 is a clinical trial in Maxillary Hypoplasia, sponsored by Ankara University.

Who is sponsoring NCT03570528?

NCT03570528 is sponsored by Ankara University.

What condition does NCT03570528 study?

NCT03570528 studies Maxillary Hypoplasia, Retrognathia, Intubation, Tomography.

Is NCT03570528 still recruiting?

NCT03570528 is currently completed. Last updated 28 January 2019.

Last reviewed 2019-01-28 · How we verify

NCT03570528

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CT Analysis of the Anatomy of the Nasotracheal Intubation Pathway of Patients With Indication of Maxillary Advancement

Completed Last updated 28 January 2019

What this trial tests

trial in Maxillary Hypoplasia in 187 participants. Completed in 1 September 2018.

Timeline

20 May 2018

Primary endpoint
1 September 2018

1 September 2018

Quick facts

Lead sponsor	Ankara University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	187
Start date	20 May 2018
Primary completion	1 September 2018
Estimated completion	1 September 2018
Sites	1 location across Turkey (Türkiye)

Conditions studied

Maxillary Hypoplasia — all drugs for Maxillary Hypoplasia →
Retrognathia — all drugs for Retrognathia →
Intubation — all drugs for Intubation →
Tomography — all drugs for Tomography →

Sponsor

Ankara University

Who can join

Adults 18 to 40, any sex, with Maxillary Hypoplasia or Retrognathia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Differences in nasotracheal intubation pathway anatomy will be observed between healthy patients and patients with maxillary retrusion. The results will clarify the nasotracheal intubation tube preference for these patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Maxillary Hypoplasia

Currently open trials in the same condition.

NCT04190953 — Upper Airway's Pressure Drop Analyses After Mandibular Advancement and Maxillary Expansion · NA · recruiting

Other Ankara University trials

Trials by the same sponsor.

NCT07441837 — Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients · Phase 2 · not yet recruiting
NCT07536490 — Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease · not yet recruiting
NCT06959433 — Lu-177 PSMA Treatment in Cell Renal Carcinoma · Phase 3 · not yet recruiting
NCT07513272 — EFFECT OF BALLS ON PAIN AND ANXIETY DURING VENIPUNCTURE IN CHILDREN · NA · not yet recruiting
NCT07536542 — Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03570528 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara University
Last refreshed: 28 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03570528.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing